Table 1. The sequences of primers used in this study.

ß-actin:

forward,5′-CCTGTACGCCAACACAGTGC-3′;

reverse, 5′- ATACTCCTGCTTGCTGATCC-3′;

Oc:

forward, 5′- CTTGAAGACCGCCTACAAAC-3′;

reverse, 5′- GCTGCTGTGACATCCATAC-3′;

ALP:

forward, 5′- GAATCAAATGTTCAGGGTGGT-3′;

reverse, 5′- TGGCACGTTAAAGGTAATCAG-3′;

Runx2:

forward,5′-CTCTTCTGGAGCCGTTTATGT-3′;

reverse, 5′- GTTTCTTAGGGTCTTGGAGTGA-3′;

Wnt1:

forward, 5′- ACAGCGTTCATCTTCGCAATCACC-3′;

reverse,5′-AAATCGATGTTGTCACTGCAGCCC-3′;

Wnt4:

forward, 5′- CTCAAAGGCCTGATCCAGAG-3′;

reverse,5′- GTCCCTTGTGTCACCACCTT-3′;

Wnt10b:

forward, 5′- TAACCACGACATGGACTTCGG-3′;

reverse,5′-TCCGCTTCAGGTTTTCCGTTA-3′;

Cyclin D1:

forward,5′-CTCCGTATCTTACTTCAAGTGCG-3′;

reverse, 5′- CTTCTCGGCAGTCAAGGGAA-3′;

ß-Catenin:

forward,5′-CACGCAAGAGCAAGTAGCTG-3′;

reverse,5′-TCTGTGATGGTTCAGCCAAG-3′;